Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[ACE inhibitor].

Hidehira Fukaya1, Tohru Izumi

  • 1Department of Cardio-angiology, Kitasato University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 13, 2006
PubMed
Summary

Angiotensin-converting enzyme (ACE) inhibitors offer significant benefits for chronic heart failure (CHF) patients. These inhibitors help manage CHF by blocking harmful neurohumoral factors, reducing hospitalizations and improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Midterm Efficacy of SubcutAneous Implantable CardioVErter-Defibrillator in ≤ 18 Year-Old CHILDREN (SAVE CHILDREN-II Registry).

Journal of arrhythmia·2026
Same author

A Case of Silicone Allergy Induced by a Subcutaneous Implantable Cardioverter Defibrillator.

Journal of arrhythmia·2026
Same author

PERSIST-PWI trial: Rationale and design of a multicenter randomized controlled trial comparing pulmonary vein isolation alone with pulmonary vein isolation plus posterior wall isolation using pulsed field ablation in patients with persistent atrial fibrillation.

Heart rhythm O2·2026
Same author

Optimizing Amiodarone Maintenance Dose to Minimize N-Desethylamiodarone Accumulation and Pulmonary Toxicity: Insights from Machine Learning and Pharmacokinetic Simulation.

Clinical drug investigation·2026
Same author

Global trend and predictors of non-labelled sacubitril-valsartan dosing: results from IKNOW-HF survey.

ESC heart failure·2026
Same author

Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.

Circulation·2026

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Chronic heart failure (CHF) is a severe cardiovascular condition characterized by high mortality, morbidity, and frequent hospitalizations.
  • Neurohumoral systems, particularly the renin-angiotensin-aldosterone system (RAAS), are often overactivated in CHF patients.
  • This activation leads to elevated levels of cardiotoxic hormones, contributing to cardiac remodeling and disease progression.

Purpose:

  • To evaluate the therapeutic and preventative role of ACE inhibitors in managing chronic heart failure.
  • To elucidate the mechanism by which ACE inhibitors mitigate the detrimental effects of RAAS activation in CHF.

Summary:

  • Activated RAAS in CHF patients leads to increased angiotensin and aldosterone, promoting cardiac remodeling.
  • ACE inhibitors effectively block the RAAS pathway, interrupting the link between neurohumoral activation and cardiac remodeling.
  • Large-scale randomized controlled trials demonstrate the efficacy of ACE inhibitors in both treating and preventing CHF.

Impact:

  • ACE inhibitors provide a crucial therapeutic strategy for managing CHF, reducing patient morbidity and mortality.
  • Blocking RAAS with ACE inhibitors alleviates the burdens associated with CHF, including frequent hospitalizations.
  • These findings highlight the importance of ACE inhibitors as a cornerstone therapy in cardiovascular medicine.

Related Experiment Videos